Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now lists an additional MeSH term 'Non-alcoholic fatty liver disease' and a related topic 'MedlinePlus Genetics', and shows the revision tag v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-18T13:51:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Removed specific related topics from the page: Non-alcoholic fatty liver disease and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-11T06:43:57.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Expanded recruitment locations to include numerous sites across the United States and internationally, and added related topics such as Non-alcoholic fatty liver disease and MedlinePlus Genetics. The HHS Vulnerability Disclosure item was removed.
    Difference
    2%
    Check dated 2025-12-20T23:59:24.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Deleted related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-13T19:29:12.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    - Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics.
    Difference
    0.0%
    Check dated 2025-12-06T14:51:26.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 under additions. Removed 'Non-alcoholic fatty liver disease', 'MedlinePlus Genetics' related topic, and Revision: v3.3.1 from deletions.
    Difference
    0.1%
    Check dated 2025-11-29T03:01:27.000Z thumbnail image

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.